|
MRFAP1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.951190E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.655900E-03 |
| Normal-vs-Stage2 |
1.702170E-01 |
| Normal-vs-Stage3 |
3.9497000000055E-05 |
| Normal-vs-Stage4 |
2.47939999997726E-06 |
| Stage1-vs-Stage2 |
6.932800E-01 |
| Stage1-vs-Stage3 |
4.006500E-02 |
| Stage1-vs-Stage4 |
6.303700E-03 |
| Stage2-vs-Stage3 |
1.409190E-01 |
| Stage2-vs-Stage4 |
5.644400E-02 |
| Stage3-vs-Stage4 |
4.848800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.219800E-04 |
| Normal-vs-AfricanAmerican |
8.796100E-02 |
| Normal-vs-Asian |
3.981000E-01 |
| Caucasian-vs-AfricanAmerican |
3.834600E-01 |
| Caucasian-vs-Asian |
6.498100E-03 |
| AfricanAmerican-vs-Asian |
3.026800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.695700E-03 |
| Normal-vs-Female |
1.781350E-04 |
| Male-vs-Female |
6.626200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.077500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.316040E-03 |
| Normal-vs-Age(61-80Yrs) |
6.30609999999754E-05 |
| Normal-vs-Age(81-100Yrs) |
2.709600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.161800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.282200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.850200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.626580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.034800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.873400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.196560E-04 |
| Classical-VS-Follicular |
2.234000E-01 |
| Classical-VS-Other |
8.149400E-01 |
| Classical-VS-Normal |
1.880410E-02 |
| Tall-VS-Follicular |
1.487910E-02 |
| Tall-VS-Other |
2.508800E-01 |
| Tall-VS-Normal |
9.33469999964132E-07 |
| Follicular-VS-Other |
5.751200E-01 |
| Follicular-VS-Normal |
3.220200E-03 |
| Other-VS-Normal |
6.341400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.076000E-03 |
| Normal-vs-N1 |
6.28710000000199E-05 |
| N0-vs-N1 |
6.540000E-02 |
|
|
